Effectively engaging with the right KOLs in rare disease
A biopharma company developing a rare disease drug needed better KOL identification and tiering; its prior approach relied on traditional consultant mapping that was slow, low-quality, and outdated. It implemented Monocl ExpertInsight and Monocl Connect to independently generate KOL lists, enabling faster identification of experts matching specific criteria and integrating with its CRM for real-time engagement data. Engagement success rate rose to 90%, up from a prior peak of 50%, an overall 40% increase in engagement success, while meeting preparation time dropped from 30 minutes to 5 minutes. A team member described the tool as "a gamechanger for finding and engaging new KOLs."
The customer is anonymised in Definitive Healthcare’s own case study — not withheld by us.
Definitive Healthcare is a claims and provider-reference data platform used by pharma commercial teams for go-to-market planning and sales targeting.
This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.
Published by Definitive Healthcare on its own site — read the original case study on definitivehc.com ↗
Related use cases
- 01Medisolv eliminated data quality issues and drove smarter marketing decisions
- 02How Boehringer Ingelheim makes every conversation at conferences count
- 03How UltraSight used data-driven strategy to identify the right markets and accelerate investor confidence
- 04How BrainsWay closed $1.3M in deals by targeting smarter
- 05Lenovo Sharpens Sales Focus With Market Intelligence
- 06How XSOLIS uses Definitive Healthcare intelligence to define the U.S. healthcare landscape